Log in

LON:SN - Smith & Nephew Share Price, Forecast & News

GBX 1,676.50
+4.50 (+0.27 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
1,659.50
Now: GBX 1,676.50
1,682.50
50-Day Range
1,630.50
MA: GBX 1,694.09
1,843.50
52-Week Range
1,383
Now: GBX 1,676.50
1,998.40
Volume1.84 million shs
Average Volume3.25 million shs
Market Capitalization£14.67 billion
P/E Ratio21.04
Dividend Yield1.65%
BetaN/A
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. Read More…

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-74017646

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£4.95 billion
Cash FlowGBX 15.50 per share
Book ValueGBX 565.70 per share

Profitability

Miscellaneous

Employees16,377
Market Cap£14.67 billion
Next Earnings Date2/20/2020 (Estimated)
OptionableOptionable

Receive SN News and Ratings via Email

Sign-up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter.


Smith & Nephew (LON:SN) Frequently Asked Questions

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the London Stock Exchange (LON) under the ticker symbol "SN."

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a dividend on Wednesday, July 31st. Stockholders of record on Thursday, October 3rd will be given a dividend of GBX 0.14 per share on Wednesday, October 30th. This represents a dividend yield of 0.62%. The ex-dividend date is Thursday, October 3rd. The official announcement can be seen at this link. View Smith & Nephew's Dividend History.

When is Smith & Nephew's next earnings date?

Smith & Nephew is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Smith & Nephew.

What price target have analysts set for SN?

10 analysts have issued 1-year price targets for Smith & Nephew's stock. Their forecasts range from GBX 1,350 to GBX 2,185. On average, they expect Smith & Nephew's stock price to reach GBX 1,710.38 in the next year. This suggests a possible upside of 2.0% from the stock's current price. View Analyst Price Targets for Smith & Nephew.

What is the consensus analysts' recommendation for Smith & Nephew?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Smith & Nephew.

Has Smith & Nephew been receiving favorable news coverage?

Media headlines about SN stock have trended somewhat positive on Saturday, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Smith & Nephew earned a media sentiment score of 1.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the near term. View News Stories for Smith & Nephew.

Who are some of Smith & Nephew's key competitors?

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Imperial Brands (IMB), Smith & Nephew (SNN), Alexion Pharmaceuticals (ALXN), Barclays (BARC), GlaxoSmithKline (GSK), Anglo American (AAL), Aviva (AV), AstraZeneca (AZN), BAE Systems (BA) and British American Tobacco Plc Ads (BATS).

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the folowing people:
  • Mr. Namal Nawana, CEO & Exec. Director (Age 48)
  • Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)
  • Mr. Mark Gladwell, Pres of Global Operations (Age 44)
  • Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)
  • Mr. Joe Metzger, Sr. VP of Marketing Services & Communications

How do I buy shares of Smith & Nephew?

Shares of SN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Smith & Nephew's stock price today?

One share of SN stock can currently be purchased for approximately GBX 1,676.50.

How big of a company is Smith & Nephew?

Smith & Nephew has a market capitalization of £14.67 billion and generates £4.95 billion in revenue each year. Smith & Nephew employs 16,377 workers across the globe.View Additional Information About Smith & Nephew.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is http://www.smith-nephew.com/.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The company can be reached via phone at +44-20-74017646.


MarketBeat Community Rating for Smith & Nephew (LON SN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  489 (Vote Outperform)
Underperform Votes:  609 (Vote Underperform)
Total Votes:  1,098
MarketBeat's community ratings are surveys of what our community members think about Smith & Nephew and other stocks. Vote "Outperform" if you believe SN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/7/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel